Viewing nowCombinationSitagliptin 10/100 mg Tablet (Dapagliflozin, Sitagliptin)
Sitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Green Cross Corporation

MFDS item code 202200068 · Approved 2022.01.04 · Insurance code 643606300
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help improve blood sugar control in patients with type 2 diabetes. The combination of sitagliptin and dapagliflozin effectively manages blood sugar levels and helps reduce the risk of complications related to diabetes. Therefore, it is used to improve blood sugar control.
One tablet of this medicine may be administered once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Patients with renal impairment The efficacy and safety of this medicine depend on renal function; evaluation of renal function before treatment and periodically after starting treatment is recommended. - No dose adjustment is necessary when the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - This medicine should not be administered when the estimated glomerular filtration rate(eGFR) is below 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication may cause serious allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, you should immediately stop taking it and consult a doctor. Acute pancreatitis may occur during the use of this medication, so if symptoms such as abdominal pain, nausea, vomiting, or fever appear, you must inform healthcare professionals immediately. This medication should not be used in patients with allergies to certain components, type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. Patients with reduced fluid volume or kidney function issues may experience low blood pressure or kidney damage, so renal function and fluid status should be carefully checked and monitored before and during use. The effectiveness of blood sugar control may vary based on kidney function, so its use is not recommended in patients with severe renal impairment. This medication may increase the risk of genital infections or urinary tract infections, so if symptoms of infection occur, immediate treatment should be sought. There is a risk of hypoglycemia, so when taken with insulin or sulfonylureas, you should be aware of symptoms of hypoglycemia and may need to adjust the dosage if necessary. Elderly patients or those with impaired liver function may experience enhanced effects of the drug, so careful evaluation before use and regular renal function testing are recommended. Pregnant or breastfeeding women are advised not to take this medication, and if pregnancy is confirmed, it should be discontinued immediately. In the case of overdose, as there is no specific antidote, appropriate treatment should be given based on symptoms, and monitoring may be needed at a hospital. This medication does not significantly affect the ability to drive or operate machinery, but caution is needed due to the possibility of hypoglycemic symptoms. Store this medication out of reach of children and keep it in its original package to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. To maintain the medication's effectiveness, it is recommended to store it at room temperature between 1 to 30 degrees Celsius.
This medication is a light yellow, oval-shaped film-coated tablet.
28 tablets/box [7 tablets/PTP (Alu-Alu) × 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.